RESPARK - Brain Q for Chronic Stroke
This study is testing a device called the Q Therapeutic System (BQ 3.0) for people who have had a stroke. This system uses very low-level electromagnetic fields to stimulate brain networks, aiming to reduce disability and help the brain recover. The study will look at how well the BQ 3.0 works and if it is safe. Researchers will measure changes in arm movement and overall disability to see if the treatment is successful. You might be able to join if you are between 18 and 80 years old, had a stroke (ischemic or hemorrhagic) between 6 months and 5 years ago, and have certain levels of arm weakness. The current recruitment status is unclear.
- Study design
- This is a single-center study with 25 participants, where everyone receives the BQ 3.0 treatment. It is an open-label study, meaning both you and the researchers will know you are receiving the treatment.
- What's involved
- You would have 5 treatment sessions per week for 3 months, with each session lasting up to 60 minutes. During sessions, you'll receive 40 minutes of stimulation with arm exercises, followed by 10 minutes of balance and leg exercises.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your progress will be checked at 3 months and 6 months after starting the interventions.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
RESPARK - Brain Q for Chronic Stroke
At a glance
Conditions
NCT07095920
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Brooks Rehabilitation Clinical Research Center
Jacksonville, Floridastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Emily Fox, PT, DPT, MHS, PhD · PRINCIPAL_INVESTIGATOR · University of Florida & Brooks Rehabilitation
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Change in Fugl-Meyer Assessment - Upper ExtremityBaseline, 3 months after, and 6 months after start of interventions
A performance measure used to assess arm function. 33 items are scored on a scale of 0 to 2, where 0=cannot perform, 1=performs partially and 2=performs fully. An increase in score reflects an improvement in arm function.
- Change from Baseline in Modified Rankin Scale (mRS)Baseline, 3 months after, and 6 months after the start of interventions
A 7-point scale used to measure the degree of disability or dependence in daily activities of people who have suffered a stroke. Scores range from 0 (no symptoms) to 6 (death). A decrease in score reflects a reduction in disability and improved independence.